(ALHC) Alignment Healthcare - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US01625V1044
ALHC: Medicare Advantage, Healthcare Plans, Senior Care
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform tailored for seniors in the United States, focusing on delivering personalized healthcare experiences through its Medicare Advantage plans. Founded in 2013 and headquartered in Orange, California, the company leverages technology and data analytics to improve health outcomes for its members. Alignment Healthcare emphasizes value-based care, offering a range of benefits and services designed to address the unique needs of seniors, including chronic disease management, telehealth services, and social determinants of health support. The company has established partnerships with providers and health systems to enhance care coordination and accessibility. For more information, visit their website at https://www.alignmenthealth.com.
Ticker Symbol: ALHC | Exchange: NASDAQ | Type: Common Stock | Country Origin: United States | GICS Sub Industry: Health Care Services
3-Month Forecast: Based on
Additional Sources for ALHC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ALHC Stock Overview
Market Cap in USD | 3,461m |
Sector | Healthcare |
Industry | Healthcare Plans |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2021-03-26 |
ALHC Stock Ratings
Growth Rating | 8.96 |
Fundamental | -1.67 |
Dividend Rating | 0.0 |
Rel. Strength | 238 |
Analysts | 4.09/5 |
Fair Price Momentum | 18.62 USD |
Fair Price DCF | - |
ALHC Dividends
No Dividends PaidALHC Growth Ratios
Growth Correlation 3m | 82.5% |
Growth Correlation 12m | 95.2% |
Growth Correlation 5y | -42.3% |
CAGR 5y | 0.57% |
CAGR/Max DD 5y | 0.01 |
Sharpe Ratio 12m | 1.32 |
Alpha | 233.42 |
Beta | 0.841 |
Volatility | 65.65% |
Current Volume | 3419.9k |
Average Volume 20d | 2988.4k |
As of May 01, 2025, the stock is trading at USD 17.72 with a total of 3,419,876 shares traded.
Over the past week, the price has changed by -3.17%, over one month by -4.83%, over three months by +15.14% and over the past year by +244.08%.
Neither. Based on ValueRay Fundamental Analyses, Alignment Healthcare is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -1.67 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALHC as of May 2025 is 18.62. This means that ALHC is currently overvalued and has a potential downside of 5.08%.
Alignment Healthcare has received a consensus analysts rating of 4.09. Therefor, it is recommend to buy ALHC.
- Strong Buy: 6
- Buy: 1
- Hold: 3
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, ALHC Alignment Healthcare will be worth about 20.8 in May 2026. The stock is currently trading at 17.72. This means that the stock has a potential upside of +17.21%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 17.8 | 0.3% |
Analysts Target Price | 17.8 | 0.3% |
ValueRay Target Price | 20.8 | 17.2% |